Emcure To Fully Acquire Zuventus For ₹7.25 Billion, Set Up New Wellness Unit

Emcure Pharmaceuticals Ltd. on Saturday said its board has approved the acquisition of 4.1 million shares in its subsidiary Zuventus Healthcare Ltd. for ₹7.25 billion, taking its ownership to 100%. These shares account for 20.42% of Zuventus’ total shareholding and will be acquired from individual shareholders, the company said in a stock exchange filing.

The deal is expected to be completed on or before September 30.

Additionally, Emcure’s board has cleared a proposal to incorporate a new wholly-owned subsidiary named Emcure Wellness Pvt. Ltd. or another name subject to government approval. Based in Pune, Maharashtra, the new entity will focus on manufacturing, promoting, and distributing pharmaceutical and related wellness products.

The proposed authorised share capital of the new company is ₹100 million, while the paid-up capital will be ₹100,000, with each share having a face value of ₹10.